The 2025 Therapeutics Market Report provides an overview of the fast-changing environment that is driving change in healthcare by introducing treatment solutions for various medical conditions. Research and development efforts drive the increasing adoption of therapeutics across oncology, neurology, and immunology while improving patient treatment efficacy.
The report explores key trends fueling the growth of the therapeutics market, including cancer immunotherapy, regenerative medicine, and digital therapeutics innovation. It also examines the role of funding initiatives and collaborative research efforts in supporting advancements. The report also profiles leading companies, biotech startups, and investors shaping this field. It provides insights into how therapeutics will transform healthcare and tackle emerging medical challenges.
This therapeutics market outlook serves as a reference for stakeholders within the market, investors, policymakers, and economic analysts, providing a snapshot of the market’s health to map its trajectory for innovation and growth in the coming years.
StartUs Insights Therapeutics Market Report 2025
- Executive Summary
- Introduction to the Therapeutics Market Report 2025
- What data is used in this Therapeutics Market Outlook?
- Snapshot of the Global Therapeutics Market
- Funding Landscape in the Therapeutics Market
- Who is Investing in the Therapeutics Market?
- Emerging Trends in the Therapeutics Market
- 5 Innovative Therapeutics Startups
Executive Summary: Therapeutics Market Report 2025
This report is created using data obtained from the Big Data and AI-powered StartUs Insights Discovery Platform, covering more than 4.7 million global companies, as well as 20K+ technologies and emerging trends. We also analyzed a sample of 3130+ therapeutics startups developing innovative solutions to present five examples from emerging therapeutics market trends.
- Industry Growth Overview: The therapeutics market has experienced a growth rate of 10.77% over the past year. More than 3130 startups are actively contributing to this landscape.
- Manpower & Employment Growth: The market employs over 6 million individuals globally, with an increase of 346K+ new jobs added in the last year.
- Patents & Grants: The therapeutics market features more than 491300 patents and 16640 grants. The patent growth rate is 3.76% yearly, with the U.S. and China leading in patent issuance.
- Global Footprint: Key hubs for therapeutics include the U.S., India, UK, Canada, and Australia, showcasing a diverse global infrastructure supporting market growth. Major city hubs encompass New York City, London, San Diego, Melbourne, and Sydney.
- Investment Landscape: The average investment value per funding round exceeds USD 35 million, with over 49140 funding rounds closed. More than 20K investors are actively engaged in the therapeutics market.
- Top Investors: Major investors include Boehringer Ingelheim, AstraZeneca, Bayer, Eli Lilly, and Ra Capital Management, collectively investing over USD 33.6 billion across numerous companies.
- Startup Ecosystem: Five innovative startups, such as Vimbo Health (digital therapeutics for depression and anxiety), SleepUp (EEG headband for sleep monitoring), EndoRobotics (non-invasive endoscopic therapy), NanoVation Therapeutics (nucleic acid-agnostic lipid nanoparticle), and BigHat Bio (antibody discovery and engineering), showcase the market’s global reach and entrepreneurial spirit.
- Recommendations for Stakeholders: Stakeholders should prioritize collaboration among researchers, investors, and regulatory bodies to drive innovation. Entrepreneurs must also focus on developing scalable solutions that address unmet medical needs. Investors should seek opportunities in emerging technologies and support early-stage companies through funding. Further, governments should facilitate growth by streamlining regulatory processes and investing in research initiatives.
Explore the Data-driven Therapeutics Market Report for 2025
The therapeutics market outlook 2025 uses data from the Discovery Platform and encapsulates the key metrics that underline the sector’s dynamic growth and innovation. Our database contains 3130+ startups and over 74 740 companies, indicating major market engagement and investment. In the past year, the therapeutics market experienced a growth rate of 10.77%, illustrating market potential and interest in therapeutic solutions. Additionally, global manpower in the therapeutics market exceeds 6 million, with an employee growth of 346K+ in the last year.
The top five country hubs US, India, UK, Canada, and Australia demonstrate the geographic diversity and dynamism of the market. Notably, major city hubs such as New York City, London, San Diego, Melbourne, and Sydney serve as focal points for activity and collaboration within the therapeutics ecosystem.
What data is used to create this therapeutics market report?
Based on the data provided by our Discovery Platform, we observe that the therapeutics market ranks among the top 5% in the following categories relative to all 20K topics in our database. These categories provide a comprehensive overview of the market’s key metrics and inform the short-term future direction of the market.
- News Coverage & Publications: The therapeutics market received coverage in over 46300 publications within the last year.
- Funding Rounds: Our database contains data on more than 49140 funding rounds.
- Manpower: The market contains more than 6 million workers, with the addition of over 346K new employees in the last year alone.
- Patents: The total number of patents in the therapeutics market surpasses 491300.
- Grants: The market has received more than 16640 grants which demonstrates support from funding bodies for therapeutic advancements.
- Yearly Global Search Growth: The therapeutics market experiences a yearly global search growth of 15.45%.
A Snapshot of the Global Therapeutics Market
The therapeutics market exhibits an annual growth of 10.77%. Our database includes 3130+ startups which indicates a vibrant entrepreneurial environment. In terms of company stages, the data reveals over 3370 early-stage startups and more than 3560 mergers and acquisitions (M&A).
The therapeutics market has over 491 300 patents filed, which underscores the commitment to research and development. A total of 55 440 applicants contribute to this patent ecosystem. Moreover, the yearly patent growth stands at 3.76%. The US leads as the top issuer of patents, with over 168 100 patents granted, followed by China with more than 71 240 patents.
Explore the Funding Landscape of the Therapeutics Market
The average investment value per funding round exceeds USD 35 million in the therapeutics market. More than 20K investors actively participate in this market. The total number of funding rounds closed has surpassed 49 140. Plus, investors have engaged with over 12 600 companies. This diverse engagement encourages innovation and enables companies to advance their research and development initiatives effectively.
Who is Investing in the Therapeutics Market?
The combined investment value of the top investors in the therapeutics market exceeds USD 33.6 billion. The following investors have significantly impacted this landscape:
- Boehringer Ingelheim has invested USD 4.6 billion across 15 companies.
- AstraZeneca has invested USD 4.5 billion in 20 companies.
- Bayer has allocated USD 4.3 billion to 20 companies.
- Eli Lilly has invested USD 3.3 billion across 51 companies.
- RA Capital Management has backed 160 companies with an investment of USD 3.2 billion.
- Orbimed has invested USD 3.2 billion in 131 companies.
- CD&R has directed USD 2.8 billion into 2 companies.
- Boston Scientific has invested USD 2.6 billion in 6 companies.
- Coloplast has allocated USD 2.6 billion across 3 companies.
- Asahi Kasei has invested USD 2.5 billion in 13 companies.
Access Top Therapeutics Innovations & Trends with the Discovery Platform
- Cancer immunotherapy is changing cancer treatment with therapies such as checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. With over 550 companies actively developing solutions in this domain, it is a fast-growing market within therapeutics. The workforce of over 41K employees and an addition of 3K+ new employees highlights the market’s commitment and resource investment in immuno-oncology. Plus, the annual trend growth rate of 15.33% suggests a steady expansion.
- Regenerative medicine is a rapidly growing field that is restoring or replacing damaged tissues and organs. The use of stem cells, tissue engineering, and gene therapy in regenerative medicine is opening up new possibilities for treating diseases and injuries. The domain’s 3050+ companies are supported by an expanding workforce of over 105K professionals, with 8K+ new employees joining in the past year alone. The annual growth rate of 9.29% indicates that while the market is expanding steadily, it is still in the maturing phase.
- Digital therapeutics, which involves the use of software and digital tools to treat conditions, is a fast-growing domain within therapeutics. By providing personalized, evidence-based interventions, digital therapeutics is improving the treatment of chronic diseases. The field is expanding rapidly with over 720 companies operating in this space, supported by a workforce of 25K+ employees. The market’s annual growth rate of 26.71% reflects the accelerating adoption of digital health solutions.
5 Top Examples from 3130+ Innovative Therapeutics Startups
The five innovative startups showcased below are picked based on data including the trend they operate within and their relevance, founding year, funding status, and more. Book a demo to find promising startups, emerging trends, or industry data specific to your company’s needs and objectives.
Vimbo Health offers Digital Therapeutics for Depression & Anxiety
South African startup Vimbo Health develops a digital therapeutic app that reduces the symptoms of depression and anxiety through cognitive behavioral therapy (CBT) techniques. The app delivers self-guided programs that are tailored to patients’ specific needs, starting with a clinical assessment to create a personalized course.
Over 7 to 12 weeks, patients build new coping skills using a structured combination of course materials, audio tools, and real-world challenges. The app provides a stigma-free, less intrusive first step into mental health care for patients to gain insights into their mental health. Further, it promotes early intervention and reduces the costs of late-stage treatment.
SleepUp makes EEG Headbands for Sleep Monitoring
UK-based startup SleepUp offers a digital therapy platform to treat insomnia with lasting results. Its clinically validated solution, approved by the Brazilian FDA, utilizes home-based sleep screening with an oximeter to identify causes of sleep disturbances. The startup’s electroencephalogram (EEG) headband which features an algorithm, monitors brain activity during sleep. This headband accurately details sleep stages from the comfort of home. SleepUp also integrates a medication management module to allow patients to reduce or withdraw sleep medications safely.
Additionally, the medicine diary tracks medication usage and side effects. With continuous monitoring and AI-powered analysis of vital signs and habits, the medicine diary personalizes therapy to improve sleep outcomes. Further, the digital therapy platform provides patients with automated, detailed reports. It also optimizes the treatment of apnea through continuous positive airway pressure (CPAP) integration and personalized recommendations.
EndoRobotics enables Non-Invasive Endoscopic Therapy
EndoRobotics is a South Korean startup that develops robotic platforms and devices to improve precision and efficiency in endoscopic procedures and training. Its ROBOPERA platform combines flexible robotics with conventional endoscopes. It features dual controllers and cable motion technology to improve surgical precision while reducing operational costs. The TraCloser device combines traction and closure functions for endoscopic submucosal dissection (ESD).
The RollingStitch system delivers suturing capabilities and offers 260-degree directional control and full or partial-thickness stitching for procedural flexibility. Additionally, with its Rolling Channel technology, single-channel endoscopes achieve dual-channel functionality for easy instrument compatibility and improved performance. The INSERTrument system automates repetitive tool insertions while reducing procedure time and clinician fatigue. Finally, the EndoCubot training solution provides a realistic simulation environment, complete with touch-based lesion positioning, therapy simulation, and lifelike patient responses.
NanoVation Therapeutics deploys Nucleic Acid-Agnostic Lipid Nanoparticle
Canadian startup NanoVation Therapeutics develops a platform centered on lipid nanoparticle (LNP) technologies. It delivers genetic medicines to targeted tissues, including extrahepatic regions. The platform integrates nucleic acid-agnostic LNP formulations and mRNA caps to improve translation efficiency.
It also integrates surface-modifying lipids to increase tolerability, and high-yield synthesis pathways to ensure scalable production. The platform’s long-circulating LNPs (lcLNP) offer improved potency, safety, and stability compared to conventional systems. Further, it addresses challenges in precise nucleic acid delivery and supports applications in treating rare genetic disorders, metabolic diseases, and solid tumors.
BigHat Bio advances Antibody Discovery and Engineering
US-based startup BigHat Bio develops next-generation antibody therapies using its Milliner platform. It combines a high-speed wet lab with machine learning technologies for full-stack antibody discovery and engineering. The platform also operates through design-build-test cycles, where machine-learning models create hundreds of antibody variants. These variants are then synthesized, purified, and tested for biophysical properties and disease activity in functional assays replicating in vivo conditions.
Additionally, the platform leverages synthetic biology, data-driven insights, and its custom laboratory information management system (LIMS) system, Reccy, to streamline laboratory operations. By integrating these capabilities, BigHat identifies and optimizes antibodies with safety and efficacy, addressing challenges in treating complex diseases such as infections, inflammation, and cancer.
Gain Comprehensive Insights into Therapeutics Trends, Startups, or Technologies
In 2025, the therapeutics market will expand as developments in AI-driven gene editing, personalized medicine, and cell therapy drive innovation. Companies will increasingly adopt these therapies to address health challenges and improve treatment options. The integration of technologies and research will allow organizations to develop effective therapeutic solutions and improve patient outcomes. These developments will optimize therapeutic practices, create new investment opportunities, and enable businesses to maintain competitiveness in a rapidly changing market landscape. Get in touch to explore all 3130+ startups and scaleups, as well as all market trends impacting 74740+ companies.
